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Letter to the Editor 
Discrimination in COVID-19 vaccination programs – A possible risk for mental health 
The World Health Organization (WHO) issued the first Emergency 
Use Listing (EUL) for the first vaccine in December 2020; nearly a year 
after the outbreak of Coronavirus Disease (COVID-19) began and was 
later declared a pandemic. The WHO has approved or is currently 
reviewing the efficacy and safety of more than 100 vaccines using 
various platforms (World Health Organization, 2021). Since then, 
numerous countries have implemented mass vaccination programs. 
Though the long-term duration of COVID-19 vaccine protection has not 
been determined, vaccination is strongly recommended if available. 
Unfortunately, there is considerable variation in the rate and efficacy of 
COVID-19 vaccination programs across countries, resulting in an 
alarming inequity of "the right to health." According to some estimates, a 
high percentage of the total population in some developed countries has 
been fully vaccinated against COVID-19, while many other countries are 
expanding the program. On the other hand, vaccination rates are 
extremely low in some other countries, primarily developing countries, 
despite the disease’s high prevalence. 
Since the burden of COVID-19 is not uniform worldwide, the pan-
demic’s emergence has drawn attention to inequities in health service 
accessibility. Previous studies have found that inequity in access to 
health services can lead to adverse health consequences for deprived 
populations (Arcaya et al., 2015). Mental health is not an exception in 
this case. Perceived interpersonal discrimination in health care is a risk 
factor for poorer mental health and psychological distress (Allen, Bal-
four et al. 2014). Today, perceived inequity is amplified by social media 
availability. Numerous studies (Boccardi and Boccardi, 2021) have 
examined the psychosocial consequences of COVID-19 infection and the 
impact of a pandemic on public mental health (Tandon, 2021a, b). The 
studies reported that individuals with lower social, medical, and eco-
nomic resources experience higher anxiety levels and depressive 
symptoms (Ettman, Abdalla et al. 2020). Furthermore, individuals in 
more affected communities experienced increased psychological distress 
due to COVID-19 (Cao, Zuo et al. 2020). 
Perceived racial discrimination in clinical care was significantly 
associated with higher levels of psychological distress among African 
Americans in a study conducted in the US during the pandemic (Cobb, 
Erving et al. 2021). Whether real or perceived, any inequity in health 
care appears to have a detrimental effect on mental health. It is worth 
noting that a particularly vulnerable group are those who have a severe 
mental illness, for whom this additional burden may exacerbate their 
condition and restrict their access to treatment services (Tandon, 2021a, 
b). 
We believe that any form of discrimination, real or perceived, in 
vaccination, the most effective strategy against COVID-19 at the 
moment, is a global issue of mental health concern. Perceived inequity 
in vaccination priorities and vaccine brand can intensify the already 
high level of uncertainty, fear of death, and loneliness (Kumar and 
Nayar, 2021), most likely via psychological phenomena such as fear of 
missing out and social exclusion. Accountable policymakers would be 
prudent to address this issue by publishing and broadcasting a vacci-
nation plan with a clear strategy and schedule. Combating misinfor-
mation spread by the media, particularly those that compare the efficacy 
and side effects of available vaccine brands, is also imperative (Tandon, 
2021a, b). 
On the other hand, the disparity in vaccination programs could affect 
pandemic control. Longer lock-down and its associated boredom, 
monotony, and economic challenges (Kumar and Nayar, 2021), along-
side perceived discrimination, can lower adherence to quarantine pro-
tocols. The risk of the emergence of new variants against which current 
vaccines are ineffective will not be eliminated until the global contagion 
cycle is broken. As a result, vaccination coverage of 75 % of the global 
population is more crucial than the complete vaccination of developed 
countries. Additionally, vaccines should be prioritized for vulnerable 
subgroups, such as those with severe mental illness (Tandon, 2021a, b). 
Equity in COVID-19 vaccination is a primary global health concern, not 
just an ethical one. 
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